Aline L Petrin, LAM Machado-Paula, A Hinkle, Luke Hovey, Waheed Awotoye, M Chimenti, B Darbro, Lucilene a Ribeiro-Bicudo, Shareef M Dabdoub, T Peter, Others
(2024).
Whole genome sequencing of a family with autosomal dominant features within the oculoauriculovertebral spectrum.
medRxiv.
Brynn Kyleakin Helm-Kwasny, Amanda Bullert, Hui Wang, Michael S Chimenti, Andrea Adamcakova-Dodd, Xuefang Jing, Xueshu Li, David K Meyerholz, Peter S Thorne, Hans-Joachim Lehmler, Others
(2024).
Upregulation of fatty acid synthesis genes in the livers of adolescent female rats caused by inhalation exposure to PCB52 (2, 2′, 5, 5′-Tetrachlorobiphenyl).
Environmental toxicology and pharmacology.
Waheed Awotoye, Ligiane a Machado-Paula, Luke Hovey, Henry Keen, Michael Chimenti, Benjamin Darbro, Shareef Dabdoub, James C Thomas, Jeffrey C Murray, Shankar Rengasamy Venugopalan, Others
(2024).
Multi-omic analyses of a twin pair with mirror image cleft lip identifies pathogenic variant in FGF20 modified by differential methylation upstream of ZFP57.
medRxiv.
Amanda J Bullert, Hui Wang, Morgan J Linahon, Michael S Chimenti, Andrea Adamcakova-Dodd, Xueshu Li, Michael E Dailey, Aloysius J Klingelhutz, James a Ankrum, Hanna E Stevens, Others
(2024).
Effects of 28-day nose-only inhalation of PCB52 (2, 2′, 5, 5′-Tetrachlorobiphenyl) on the brain transcriptome.
Toxicology.
Francoise a Gourronc, Michael S Chimenti, Hans-Joachim Lehmler, James a Ankrum, Aloysius J Klingelhutz
(2023).
Updating “Dataset of transcriptomic changes that occur in human preadipocytes over a 3-day course of exposure to 3, 3′, 4, 4′, 5-Pentachlorobiphenyl (PCB126)” with additional data on exposure to 2, 2′, 5, 5′-tetrachlorobiphenyl (PCB52) or its 4-hydroxy metabolite (4-OH-PCB52).
Data in brief.
Brittany P Todd, Zili Luo, Noah Gilkes, Michael S Chimenti, Zeru Peterson, Madison R Mix, John T Harty, Thomas Nickl-Jockschat, Polly J Ferguson, Alexander G Bassuk, Others
(2023).
Selective neuroimmune modulation by type I interferon drives neuropathology and neurologic dysfunction following traumatic brain injury.
Acta neuropathologica communications.
Jordan L Kohlmeyer, Joshua J Lingo, Courtney a Kaemmer, Amanda Scherer, Akshaya Warrier, Ellen Voigt, Juan a Raygoza Garay, Gavin R McGivney, Qierra R Brockman, Amy Tang, Others
(2023).
CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression.
Clinical Cancer Research.
Francoise a Gourronc, Brynn K Helm, Larry W Robertson, Michael S Chimenti, Hans-Joachim Lehmler, James a Ankrum, Aloysius J Klingelhutz
(2022).
Transcriptome sequencing of 3, 3′, 4, 4′, 5-Pentachlorobiphenyl (PCB126)-treated human preadipocytes demonstrates progressive changes in pathways associated with inflammation and diabetes..
Toxicology in Vitro.
Francoise a Gourronc, Brynn K Helm, Larry W Robertson, Michael S Chimenti, Hans-Joachim Lehmler, James a Ankrum, Aloysius J Klingelhutz
(2022).
Dataset of transcriptomic changes that occur in human preadipocytes over a 3-day course of exposure to 3, 3′, 4, 4′, 5-Pentachlorobiphenyl (PCB126).
Data in brief.
Joshua Lingo, Jordan Kohlmeyer, Courtney Kaemmer, Amanda Scherer, Ellen Voigt, Michael Chimenti, Munir Tanas, Varun Monga, Ben Darbro, David Meyerholz, Others
(2022).
Abstract A02: MEK-CDK4/6 inhibition induces plasma cell tumor infiltration and sensitizes de novo MPNSTs to immune checkpoint blockade.
Cancer Immunology Research.